NF2 and schwannoma: It however failed to significantly slow schwannoma development in a genetically engineered mouse (GEM) NF2 model (PostnCre;Nf2fl/fl) in which mice naturally develop schwannomas in dorsal root and cranial ganglia and have progressive hearing loss; although these are variable in time and rate of development [35].